NASDAQ: LGVNLongeveron Inc Stock Ownership - Who owns Longeveron?
Insider buying vs selling
Have Longeveron Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul T. Lehr | General Counsel Secretary | 2026-07-01 | 13,143 | $0.73 | $9.58kSell |
| Stephen H. Willard | Chief Executive Officer | 2026-07-01 | 18,046 | $0.73 | $13.16kSell |
| Devin Blass | CTO SVP of CMC | 2026-07-01 | 15,808 | $0.73 | $11.52kSell |
| Nataliya Agafonova | Chief Medical Officer | 2026-07-01 | 22,505 | $0.73 | $16.41kSell |
| Lisa Locklear | Chief Financial Officer | 2026-07-01 | 22,505 | $0.73 | $16.41kSell |
| Paul T. Lehr | General Counsel Secretary | 2026-04-01 | 5,611 | $1.12 | $6.28kSell |
| Nataliya Agafonova | Chief Medical Officer | 2026-04-01 | 13,145 | $1.12 | $14.72kSell |
| Devin Blass | CTO SVP of CMC | 2026-04-01 | 8,633 | $1.12 | $9.67kSell |
| Lisa Locklear | Chief Financial Officer | 2026-04-01 | 13,145 | $1.12 | $14.72kSell |
| Stephen H. Willard | Chief Executive Officer | 2026-04-01 | 4,740 | $1.12 | $5.31kSell |
LGVN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LGVN insiders and whales buy or sell their stock.
LGVN Shareholders
What type of owners hold Longeveron Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donald M. Soffer | 44.04% | 13,717,945 | $8.16M | Insider |
| Joshua Hare | 4.42% | 1,375,310 | $818.31k | Insider |
| Stephen H. Willard | 2.48% | 771,681 | $459.15k | Insider |
| Paul T. Lehr | 1.85% | 575,423 | $342.38k | Insider |
| Vanguard Capital Management LLC | 1.74% | 542,032 | $322.51k | Institution |
| Millennium Management LLC | 1.43% | 446,725 | $265.80k | Institution |
| Lisa Locklear | 1.42% | 443,181 | $263.69k | Insider |
| Nataliya Agafonova | 1.38% | 430,914 | $256.39k | Insider |
| Devin Blass | 1.37% | 425,735 | $253.31k | Insider |
| Mohamed Wael Ahmed Hashad | 1.35% | 420,904 | $250.44k | Insider |
LGVN vs Biotech Stocks
Longeveron Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.